Fresenius Medical Care Deutschland GmbH
44
5
5
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.6%
6 terminated/withdrawn out of 44 trials
82.4%
-4.2% vs industry average
7%
3 trials in Phase 3/4
7%
2 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (44)
Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony
Role: lead
PD Catheter Data Collection
Role: lead
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
Role: lead
Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients
Role: lead
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Role: collaborator
Analysis of Paediatric Treatments With multiFiltratePRO
Role: lead
Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine
Role: lead
Analysis of TPE Treatments With multiFiltratePRO
Role: lead
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
Role: lead
Retrospective Data Analysis of CKRT (Continuous Kidney Replacement Therapy) Treatments in Adult Mode With multiFiltratePRO
Role: lead
Efficacy and Tolerability of the APD Treatment in PAED Patients
Role: lead
Clinical Performance of the New Plasma Filter PX2 in TPE Treatments
Role: lead
Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy
Role: lead
Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online Hemodiafiltration
Role: lead
Safety and Performance Evaluation of multiPlus Dialysate During CRRT
Role: lead
Must Cannulation Technique of Vascular Access in Patients Undergoing Haemodialysis: Contributions for a Safe Nursing Intervention
Role: lead
Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis Patients in Turkey
Role: lead
Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy
Role: lead
Comparison of Efficacy and Tolerability of APD Treatment With Different PD Cyclers
Role: lead
Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI
Role: lead